Systems, devices, and methods for analyte monitoring and benefits thereof
AssigneeAbbott Diabetes Care Inc.
InventorsYelena Nabutovsky, Matthew S. D. Kerr, Gregory J. Roberts, Jennifer M. Joseph
Life of this patent
Estimating the term…
Loading patent…
AssigneeAbbott Diabetes Care Inc.
InventorsYelena Nabutovsky, Matthew S. D. Kerr, Gregory J. Roberts, Jennifer M. Joseph
Estimating the term…
A method of treatment of a type 2 diabetic patient includes selecting a type 2 diabetic patient having a predetermined comorbidity for treatment, initiating a continuous glucose monitor regimen for the selected type 2 diabetic patient, wherein after six months of initiation of the continuous glucose monitor regimen, a rate of hospitalization for a predetermined diagnostic category of the selected patient having the predetermined comorbidity is reduced by at least 12% relative to an average rate of hospitalization for the predetermined diagnostic category of selected patients having the predetermined comorbidity without the continuous glucose monitor regimen.
A system to establish and monitor an analyte monitor regimen of a user comprising:
Dependencies are inferred from the claim text.